Moderna to seek FDA authorization for lower-dose Covid-19 vaccine for children under 6
The following is an excerpt from MedPage. Moderna’s two-dose Covid-19 vaccine regimen for the youngest children was safe and met its primary immunogenicity endpoint, the manufacturer announced on Wednesday. An interim analysis of the phase II/III KidCOVE study found that two 25 μg doses of Moderna’s vaccine in two age groups — 6 months to under […]
Continue reading Moderna to seek FDA authorization for lower-dose Covid-19 vaccine for children under 6 on sharylattkisson.com.
